Scitech and the Plough Center Announce Manufacturing Agreement
globenewswire.com
news
2022-10-20 00:00:00

GROSSE POINTE FARMS, Mich., Oct. 20, 2022 (GLOBE NEWSWIRE) -- SciTech Development is pleased to announce that it has signed a $600K manufacturing agreement with The Plough Center for Sterile Drug Delivery Systems. The Plough Center will deliver the clinical supply of SciTech's lead cancer drug candidate, ST-001 nanoFenretinide. Delivery of the drug is expected in Q4 2022, which will be immediately followed by SciTech's first human clinical trial using ST-001 for Lymphoma. (ClinicalTrials.gov Identifier: NCT04234048).
